Comparison
Abnormal Fetal Central Nervous System Morphology C5706143 vs 17q11 2 Microduplication Syndrome C3495679
Clinical comparison between Abnormal Fetal Central Nervous System Morphology and 17q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
Abnormal Fetal Central Nervous System Morphology C5706143
Structural abnormalities of the fetal brain or spine detected during pregnancy. These require thorough evaluation and specialized care. Management depends on the specific condition and its severity.
17q11 2 Microduplication Syndrome C3495679
A genetic disorder caused by duplication of a segment on chromosome 17. Individuals may have developmental delays, behavioral concerns, and physical features. Treatment focuses on early intervention.
6 comparison axes
Onset
Abnormal Fetal Central Nervous System Morphology C5706143
Variable
17q11 2 Microduplication Syndrome C3495679
0-null
Onset patterns differ
Severity
Abnormal Fetal Central Nervous System Morphology C5706143
severe
17q11 2 Microduplication Syndrome C3495679
moderate
Different severity levels
Chronic
Abnormal Fetal Central Nervous System Morphology C5706143
Chronic
17q11 2 Microduplication Syndrome C3495679
Chronic
Differing course
Communicable
Abnormal Fetal Central Nervous System Morphology C5706143
No
17q11 2 Microduplication Syndrome C3495679
No
Different transmission
Body System
Abnormal Fetal Central Nervous System Morphology C5706143
neurologic
17q11 2 Microduplication Syndrome C3495679
congenital
Same/different system
Category
Abnormal Fetal Central Nervous System Morphology C5706143
neurologic
17q11 2 Microduplication Syndrome C3495679
genetic
Different category
Bottom line
abnormal-fetal-central-nervous-system-morphology-C5706143 and 17q11-2-microduplication-syndrome-C3495679 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abnormal Fetal Central Nervous System Morphology C5706143 | 17q11 2 Microduplication Syndrome C3495679 | Discriminating power |
|---|---|---|---|
| Timing of recognition | Usually detected during pregnancy when imaging shows abnormal brain or spinal structure. | Present from conception, but often recognized postnatally; supplied onset data are incomplete. | High |
| Main clinical clue | A structural CNS abnormality whose symptoms depend on the specific lesion and are not uniform. | Developmental delay, behavioral concerns, and variable physical features may occur. | Moderate |
| Cause | A descriptive finding with many possible causes; etiology may remain unknown. | Extra chromosomal material at 17q11.2, confirmed only by genetic testing. | High |
When to favor each condition
Choose Abnormal Fetal Central Nervous System Morphology C5706143 when
Prenatal imaging identifies abnormal fetal brain or spine structure.
This label describes the imaging finding before a specific cause is established.
High
No chromosomal duplication has been confirmed.
Morphology alone does not establish 17q11.2 microduplication syndrome.
High
Pregnancy counseling concerns the structural lesion.
Management depends on lesion type, associated findings, and severity.
Moderate
Choose 17q11 2 Microduplication Syndrome C3495679 when
Genetic testing confirms duplication of 17q11.2.
The syndrome label requires laboratory confirmation and clinical correlation.
High
Postnatal developmental or behavioral concerns accompany a compatible genetic result.
These features fit the supplied syndrome description better than an imaging-only label.
Moderate
Family testing or variant interpretation is needed.
Inheritance, penetrance, and significance are not established by the concept name alone.
Moderate
How key tests differ
| Test | Abnormal Fetal Central Nervous System Morphology C5706143 | 17q11 2 Microduplication Syndrome C3495679 | Interpretation |
|---|---|---|---|
| Prenatal ultrasound | May show a fetal brain or spinal structural abnormality. | No specific prenatal appearance is established from the supplied data. | An imaging abnormality is a finding, not proof of this syndrome. |
| Fetal or postnatal MRI | May clarify CNS anatomy when clinically appropriate. | MRI findings are not defined as diagnostic for the duplication. | Use MRI to characterize structure, not to confirm chromosomal dosage. |
| Chromosomal microarray | May be normal or identify one of several possible causes. | Shows duplication involving 17q11.2 when the syndrome is confirmed. | Laboratory and clinician review should determine clinical significance. |
Prognosis comparison
Abnormal Fetal Central Nervous System Morphology C5706143
- Outcome
- Highly variable and not established from the finding name alone.
- Factors
- Lesion type, associated anomalies, gestational age, and identified cause.
17q11 2 Microduplication Syndrome C3495679
- Outcome
- Often involves ongoing developmental support, but severity varies.
- Factors
- Duplication extent, involved genes, inheritance, and comorbidities.
Time frame: From pregnancy into childhood or longer; exact course is not established.
Confirmatory testing, specialist assessment, and individualized follow-up determine interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic or developmental impact | Ranges with the specific brain or spinal abnormality and is not predictable from the label. Developmental delay and behavioral concerns may occur, with variable severity. Neither concept has a single established complication profile. |
| Need for specialized care | May require maternal-fetal, neonatal, and neurologic follow-up. Often centers on developmental surveillance and early intervention. Care should be individualized; no treatment dose is implied. |
| Diagnostic uncertainty | The cause may remain unidentified despite imaging. Expression and significance can vary even with a detected duplication. Avoid treating either result as a complete prognosis. |
Patient education highlights
- HighDifferent categories
One is an abnormal prenatal structural finding; the other is a genetic syndrome. They are not interchangeable.
- HighFinding versus diagnosis
Abnormal fetal CNS morphology requires further evaluation and does not by itself name the cause.
- MediumVariable outlook
Outcomes depend on the exact lesion or genetic result, associated findings, and clinical assessment.